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Aim: The aim of the present study was to develop a new model system to study Propionibacterium acnes
bioﬁlms. This model should be representative for the conditions encountered in the pilosebaceous unit.
Methods and results: The new model, consists of an artiﬁcial sebum pellet supported by a silicone disc.
Sebum pellets were inoculated with various P. acnes strains isolated from both normal and acneic skin.
Growth and bioﬁlm formation was veriﬁed by conventional plating at different time points, as well as by
resazurin assays and ﬂuorescence microscopy after LIVE/DEAD staining. The artiﬁcial sebum pellets were
also used in assays to measure the production of certain virulence factors implicated in the pathogenesis
of acne, including lipase, protease and the presence of CAMP factors.
Conclusion: The artiﬁcial sebum model can sustain bioﬁlm growth of P. acnes, as was determined by
increasing CFU counts for up to 1 week after inoculation. Metabolic activity and bioﬁlm formation were
conﬁrmed using resazurin staining and ﬂuorescence microscopy respectively. The production of viru-
lence factors in this model was demonstrated as well.
© 2017 Elsevier Ltd. All rights reserved.1. Introduction
Propionibacterium acnes (recently renamed as Cutibacterium
acnes [1]) is an anaerobic but aerotolerant member of the skin
microbiome, naturally inhabiting the human pilosebaceous units
[2e5]. These pilosebaceous units consist of a hair follicle and an
associated sebum gland, and hormonal imbalance can stimulate
sebocyte proliferation and lead to increased sebum production.
This sebum overproduction, combined with an altered follicular
growth can result in an obstruction of the pilosebaceous unit,
leading to the formation of microcomedones. These comedones are
anaerobic and lipid-rich micro-environments that provide P. acnes
with ideal growth conditions and an ample supply of the necessary
nutrients [6e8]. When P. acnes colonizes the pilosebaceous unit
and starts proliferating, the host immune system is stimulated,
resulting in an increased inﬂammatory response [9,10]. Moreover,
P. acnes can produce multiple virulence factors such as lipases,
proteases and the ChristieeAtkinseMunch-Petersen (CAMP)rs, ChristieeAtkinseMunch-
cal Microbiology, Ghent Uni-
m.factors, that degrade host tissue and lead to further activation of the
human immune system. For example, lipases break down tri-
glycerides thereby releasing free fatty acids that act as damage
associated molecular patterns [11e17].
Previous work has shown that P. acnes can form bioﬁlm-like
structures inside the pilosebaceous unit [5,18]. Since bioﬁlms are
typically more refractory to antibiotic treatment, it is difﬁcult to
completely eradicate the infection [19]. This could explain the need
for a prolonged antibiotic treatment, and the pattern of relapse and
outbreaks commonly observed in acne [20].
One of the contributing factors in the etiology of acne is an
increased sebum production and this sebum is the main source of
nutrients for P. acnes. Human sebum is normally produced through
holocrine secretion by the sebocytes and contains approx. 50%
triglycerides, 25% wax esters, 15% squalene, 8% free fatty acids and
2% cholesterol [21e26].
It is widely accepted that bacterial biochemistry depends on the
nutrients that are present, and Yu et al. [27] recently demonstrated
that the secreted proteome of P. acnes also varies in different
growth media. Using in vitro models providing nutrient-poor con-
ditions resembling the interior of the pilosebaceous unit may lead
to useful insights in the biology and virulence of P. acnes. In the
present study we developed an artiﬁcial sebum (based on the
composition of synthetic sebum proposed by Wertz et al. [26]) by
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essential growth factors not provided by the lipids. This medium
was subsequently used in an in vitro bioﬁlm model to study various
aspects of the biology of P. acnes. Using topical or oral antibiotics is a
cornerstone in the treatment of acne vulgaris [28,29]. However,
prolonged therapy with low doses of antibiotics has led to the
emergence of antibiotic resistance since the end of the 1970's [30].
Antibiotic resistance to erythromycin and a reduced sensitivity to
clindamycin, both commonly used topical antibiotics during the
treatment of acne, are now found worldwide [31e33].
2. Materials and methods
2.1. Strains and culture conditions
Ten Propionibacterium acnes strains were tested (Table 1).
Strains were cultured in reinforced clostridial medium (RCM) or on
reinforced clostridial agar (RCA) (LabM, Heywood, UK). All cultures
were grown at 37 C under anaerobic conditions (generated using
the Anaerogen Compact system (Oxoid, Aalst-Erembodegem,
Belgium) or the Gaspak EZ system (BD, VWR, Leuven, Belgium))
[34]. Planktonic cultures were obtained by inoculating RCM with a
few colonies from 3 to 5 day old pure cultures and incubating
anaerobically for 24 h. Bioﬁlms in 96-well microtiter plates (MTP,
SPL Life Sciences, VWR, Leuven, Belgium) were formed starting
from these 24 h old planktonic cultures. The cultures were diluted
with RCM to an optical density of 1.0 at 590 nm (corresponding to
approx. 2.5  108CFU/mL). 100 mL of this suspension was then
transferred to the MTP and incubated anaerobically for 4 h to allow
cells to adhere to the bottom of the wells. Subsequently, the su-
pernatant containing the planktonic cells was removed and the
wells were carefully washed with 100 mL physiological saline (PS,
0.9% NaCl, AppliChem-Panreac, Darmstadt, Germany). After
removing the PS, 100 mL RCM was added and the plates were
further incubated for 20 h, producing mature bioﬁlms. Staphylo-
coccus aureus LMG8224, obtained through the BCCM/LMG Bacteria
Collection (Ghent, Belgium), and Streptococcus agalactiae (an isolate
from our own collection) were used in the CAMP test. These strains
were ﬁrst resuscitated on Columbia agar plates containing sheep
blood (BD, Erembodegem, Belgium).
2.2. Production and inoculation of sebum pellets
The artiﬁcial sebum is composed of 2 g tripalmitin, 300 mg
palmitic acid, 100 mg cholesterol, 50 mg tocopherol acetate,
0.55 mL triolein, 1.437 mL jojoba oil and 0.877 mL squalene (allTable 1
Propionibacterium acnes strains used in the present study.
Strain Biological origin Type
LMG16711T,a Human, acneic skin IA1
SK137b Human, acneic skin IA1
SK182b Human, acneic skin IA1
HL001PA1b Human, normal skin II
HL030PA1b Human, normal skin IB
HL030PA2b Human, normal skin IA2
HL037PA1b Human, normal skin IA2
HL053PA1b Human, acneic skin IA1
HL060PA1b Human, acneic skin II
HL063PA1b Human, normal skin IA1
T type strain.
a This strain was obtained from the BCCM/LMG Bacteria Collection (Gent,
Belgium).
b These strains were obtained from BEI Resources, NIAID, NIH (Manassas, VA,
United States).acquired from Sigma-Aldrich, Bornem, Belgium). Each component
was chosen to represent a group of physicochemically related
components found in human sebum (e.g. palmitic acid represents
the free fatty acids). The components were heated to 85 C and
mixed to a homogenous oil, which was subsequently autoclaved.
Next, the sterilized oil was mixed with 1 mL double concentrated
RCA and 1 mL double concentrated RCM, providing other essential
nutrients. While still warm, 50 mL of this artiﬁcial sebum was
added to previously autoclaved medical grade silicone discs
(diameter of 6 mm, thickness of 4 mm); the artiﬁcial sebum was
then allowed to solidify and to adhere to the discs, forming sebum
pellets.
These pellets were subsequently transferred to a 48-well MTP
(Thermo-Fisher, Waltham, MA, United States). 24 h old planktonic
P. acnes cultures in RCM were centrifuged for 5 min at 2200g
(Eppendorf centrifuge 5804 R, Eppendorf, Hamburg, Germany), the
supernatant was discarded, and cells were resuspended in 2.5 mL
phosphate buffered saline (PBS, 0.14 M NaCl, 0.003 M KCl (Merck,
Overijse, Belgium), 0.0101 M Na2HPO4 (Sigma) and 0.0018 M
KH2PO4 (Sigma), pH 7.4). To ensure complete removal of residual
RCM, this washing step was repeated twomore times. The resulting
bacterial suspensionwas set to an optical density of 0.05 at 590 nm
(corresponding to approx. 5  106CFU/mL) and 750 mL was used to
inoculate the pellets. After 15 min of incubation at 37 C, the sus-
pensionwas aspirated and the pellets were washed with 750 mL PS,
which was subsequently removed. A schematic overview of this
procedure is shown in Fig. 1.2.3. Bioﬁlm formation on artiﬁcial sebum pellets
After 0 h, 24 h, 48 h, 72 h and 1 week of anaerobic incubation at
37 C, the inoculated artiﬁcial sebum pellets were transferred to an
Eppendorf tube containing 2 mL PBS. These tubes were then vor-
texed for 2 min and sonicated for 5 min (40 kHz). This process was
repeated, after which a serial dilution of these suspensions was
made to determine the number of CFU through conventional
plating. To verify that cells were not damaged during sonication,
planktonic cultures were sonicated one, two or three times and
plated to estimate the cell count after the increasing sonication
steps. No difference was observed in number of CFU recovered,
compared to cultures that were not sonicated (data not shown).
Cell viability after 1 week incubation was assessed by measuring
metabolic activity, using a resazurin-based staining (CellTiter-Blue
(CTB), Promega, Leiden, The Netherlands). 2.1 mL stock solution of
CTB was diluted with 10.5 mL PS. Pellets were transferred to a 48-
well MTP and 1 mL of this diluted CTB was added to the wells
containing the pellets. The platewas covered and incubated at 37 C
for 2 h shaking at 600 rpm. Subsequently 100 mL was transferred to
a 96-well MTP and ﬂuorescence (excitation wavelength: 560 nm/
emission wavelength: 590 nm) was measured using an EnVision
multilabel reader (Perkin Elmer).
Bioﬁlm formationwas visualized using ﬂuorescence microscopy
as well as confocal microscopy. Pellets incubated for 7 days were
stained with SYTO9 (excitation wavelength: 485 nm/emission
wavelength: 530 nm) and propidium iodide (excitation wave-
length: 485 nm/emission wavelength: 630 nm) (LIVE/DEAD Bac-
Light Bacterial Viability Kit, Thermo-Fisher) (3 mL of both dyes per
mL PS, staining for 10 min at room temperature). An EVOS FL Auto
Imaging System ﬂuorescence microscope (Life Technologies,
Carlsbad, California, USA) with a 2, 10 or 20 objective and
appropriate ﬁlter cubes, was used to visualize both live and dead
cells. For confocal imaging, a Nikon C1si confocal laser scanning
microscope equipped with a Plan Apo VC 40 objective lens
(Nikon) was used to visualize the live cells.
Fig. 1. Picture of the artiﬁcial sebum pellet on top of the silicone disc and schematic representation of the inoculation process used.
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The production of lipases and proteases by P. acnes grown on
artiﬁcial sebum (7-day old cultures in order to have a sufﬁcient cell
count), as well as the co-hemolytic potential (production of CAMP
factors) was assessed. The production of these virulence factors in
bioﬁlms grown on artiﬁcial sebum was then compared to the
production in 24 h old planktonic cultures and bioﬁlm grown - for a
total of 24 h - in MTP. At those time points the P. acnes cells are in
the mid to late exponential growth phase.
Lipase production was determined in planktonic cell cultures
and bioﬁlm cultures using the ﬂuorogenic substrate 4-
methylumbelliferyl (4-MU) oleate (Sigma) [34]. Sterile superna-
tant was obtained by centrifuging the supernatant of 24 h-old
planktonic cultures or the collected supernatant of bioﬁlm cultures
in 96-well MTP at 4500g for 10 min and ﬁltering through 0.22 mm
membranes (Millipore, Overijse, Belgium). The substrate solution
was prepared by dissolving 4-MU-oleate in dimethylsulfoxide
(DMSO, Sigma) to a concentration of 0.4 mg/mL DMSO. Next, 100 mL
sterile supernatant and 50 mL substrate solutionwere combined in a
black 96-well MTP (Perkin Elmer). To quantify lipase activity on the
pellets, the pellets were transferred to the wells of a black 96-well
MTP and 100 mL sterile RCM was added together with 50 mL of the
substrate. Finally, the ﬂuorescence (excitationwavelength: 355 nm/
emission wavelength: 460 nm) was measured using an EnVision
multilabel plate reader every 5 min for at least 6 h. The slope at the
beginning of the reaction was then calculated and standardized for
the amount of cells present.
The production of protease was determined using the EnzChek
protease assay (Invitrogen, Paisley, UK) according to the manufac-
turer's instructions. Brieﬂy, 100 mL supernatant from planktonic
cells and bioﬁlm cells grown in a 96-well MTP was collected as
described above. The supernatant was transferred to a black 96-
well MTP and 100 mL of the substrate solution (10 mg/mL) was
added. The plate was incubated, protected from light, for 1 h at
37 C and ﬂuorescence (excitation wavelength: 485 nm/emission
wavelength: 530 nm) was measured using an EnVision multilabel
plate reader. To quantify protease production in bioﬁlms grown onartiﬁcial sebum pellets, the pellets were transferred to a 2 mL
Eppendorf tube together with 100 mL sterile RCM and 100 mL sub-
strate solution. After 1 h incubation at 37 C, the solution was
transferred to a black 96-well MTP to measure the ﬂuorescence.
The ability to produce CAMP factors was assessed using the
CAMP test. To this end, S. aureus was streaked in the center of a
Columbia agar plate containing 4% sheep blood, and P. acnes strains
were streaked perpendicular, 1 cm from the S. aureus streak. As a
positive control, S. agalactiae, a known producer of CAMP factors,
was also streaked perpendicular to S. aureus. A clear arrowhead
between the S. aureus streak and the one from P. acnes indicates the
production of CAMP factors. To measure the production of CAMP
factors by planktonic and sessile cells, a modiﬁcation of the he-
molysis assay, described by Brackman et al. [35] was used. 200 mL
supernatant from planktonic cultures and MTP-grown bioﬁlms
were collected as described above. This supernatant was trans-
ferred to a 2 mL Eppendorf tube together with 200 mL supernatant
of a planktonic S. aureus culture grown for 24 h in RCM, and 800 mL
of a 4% sheep blood (Biotrading, Keerbergen, Belgium) suspension
in PBS. The tubes were incubated for 24 h and 100 mL was trans-
ferred to a ﬂat bottom 96-well MTP (SPL Life Sciences) after
centrifuging at 100g for 2 min. Finally, the absorbance was
measured at 420 nm using an EnVision multilabel plate reader. To
assess the possible production of CAMP factors in bioﬁlms grown
on artiﬁcial sebum pellets, the same experimental setup was used.
However, 200 mL sterile RCM and a pellet were now added to an
Eppendorf tube together with 200 mL S. aureus supernatant and
800 mL 4% sheep blood in PBS.
2.5. Statistics
All experiments were repeated at least three times and data
were analyzed using SPSS Statistics version 23.0 (SPSS, Chicago, IL,
United States). Normality of the data was determined using the
Shapiro-Wilk test. Depending on the normality, the data were
further analyzed using a t-test or Mann-Whitney U test, or an
ANOVA test or Kruskal-Wallis test. A p < 0.05 was considered sta-
tistically signiﬁcant.
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3.1. P. acnes bioﬁlm formation in the artiﬁcial sebum model
Growth of P. acnes on the artiﬁcial sebum pellets was assessed at
different time points, using conventional plating techniques. The
pellets were inoculated using a suspension containing a low cell
count (approximately 5  106 CFU/mL) in order to observe actual
cell growth and increase in CFU in contrast to survival of theFig. 2. Microscopy images of P. acnes bioﬁlms on artiﬁcial sebum pellets following LIVE/DEA
propidium iodide (excitation wavelength: 485 nm/emission wavelength: 630 nm)). The grey
that were produced during 1 week incubation and while red clusters are dead cells. (aed) F
60 magniﬁed (scale bar: 2000 mm), (b) HL030PA1 300 magniﬁed (scale bar: 400 mm); (
magniﬁed (scale bar: 200 mm). (e) A 3-D confocal microscopy image of P. acnes bioﬁlm strain
interpretation of the references to colour in this ﬁgure legend, the reader is referred to theinoculated cells. Pellets were then analyzed after inoculation and
after 1, 2, 3 and 7 days of anaerobic incubation. For all P. acnes
strains tested, growth was observed with the number of CFU
increasing from approx. 104e105 CFU per pellet to approx. 107 CFU
per pellet after 7 days of incubation (Supplementary Fig. 1).
Cell viability (as assessed by measuring metabolic activity) of
the cells after 1 week growth on the artiﬁcial sebum pellets was
measured using a resazurin staining (CTB) assay. All pellets inoc-
ulated with the strains tested generated ﬂuorescence signalsD staining (SYTO9 (excitation wavelength: 485 nm/emission wavelength: 530 nm) and
structure is the artiﬁcial sebum pellet itself, green structures are live cells and bioﬁlm
luorescence microscopy images of bioﬁlms on the artiﬁcial sebum pellet. (a) HL030PA1
c) type strain LMG16711 300 magniﬁed (scale bar: 400 mm) and (d) HL060PA1 600
HL060PA1 on artiﬁcial sebum pellet (40magniﬁed), only live cells are visualized. (For
web version of this article.)
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indicating metabolic activity of the cells present after 7 days of
incubation on the artiﬁcial sebum pellets (Supplementary
Fig. 2).While CTB staining is a convenient alternative to plating in
order to measure bacterial growth, there is no strong correlation
between both methods. For example, P. acnes HL060PA1 generates
low ﬂuorescence signals using the CTB assay, but can reach more
than 107 cells/pellet after 1 week of incubation. Regardless, CTB
staining of bioﬁlms grown in the artiﬁcial sebum model allows to
gain insight in the metabolic state of the bacteria, which can be
important when testing novel antibacterial or anti-acne compo-
nents. Some components might not kill the bacteria, but interfere
with other cellular processes and this could be observed using CTB
staining.
Bioﬁlm formation on the pellets was conﬁrmed using micro-
scopy after a LIVE/DEAD staining of the inoculated pellets (Fig. 2).
Fluorescence microscopy imaging has indeed revealed the forma-
tion of bioﬁlm like structures containing live cells (as represented
by green clusters). The small fraction of red clusters, indicating
dead cells, could be due to the slow-growing nature of P. acnes.
These pictures, combined with the plating results and the viability
assay, conﬁrm bacterial growth of P. acnes on the artiﬁcial sebum
pellets. The in vitro artiﬁcial sebum model, is an alternative toFig. 3. (a) Fluorescence-time curves obtained with P. acnes SK137. The produced lipase hydro
over time. (b) Slopes at the start of the reaction, normalized for 108 cells. Mean ± SD (numb
compared to planktonic cells, ** higher lipase activity on the artiﬁcial sebum pellets compaexisting bioﬁlm models for acne-related P. acnes research. Most
models to study bacterial bioﬁlms are based on microtiter plates,
glass beads or use a ﬂow cell which has a continuous supply of fresh
medium [36]. However, in case of bioﬁlm formation by P. acnes in
acne, these methods are not particularly relevant. The human skin,
the natural environment of this bacterium, is a lipid-rich environ-
ment in which free water and nutrients are limited [37]. These
conditions are mimicked in the artiﬁcial sebummodel, unlike most
other bioﬁlm models used in current acne-related P. acnes research
[38e41]. In addition, this model is technically not-demanding and
inexpensive, and allows the gap to be bridged between other
in vitro models and more complex animal models [42,43].
3.2. Production of virulence factors
We determined the production of virulence factors by P. acnes
grown in planktonic cultures (24 h), in bioﬁlms in MTP (4 h adhe-
sion followed by 20 h of additional incubation) and in bioﬁlms
grown on artiﬁcial sebum (incubated for 7 days). These time points
were chosen in order to have cells inmid to late exponential growth
and to have a sufﬁcient number of cells to allow quantiﬁcation of
virulence factor production.
Using the ﬂuorogenic substrate 4-MU-oleate, lipase productionlyzes 4-MU oleate releasing the ﬂuorophore, causing an increasing ﬂuorescence signal
er of replicas n > 3). * signiﬁcantly higher lipase activity on the artiﬁcial sebum pellets
red to planktonic cells and compared to bioﬁlm in a MTP, one-way ANOVA.
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grown in a MTP and grown on artiﬁcial sebum pellets. In this assay,
ﬂuorescence is measured over time, resulting in curves (Fig. 3a) for
which the slopes in the early stages of the reaction can be used as a
measurement of the amount of lipase that is present. Given that the
different growth conditions result in different ﬁnal cell numbers,
the measured slopes were normalized to 108 cells (Fig. 3b). For 6
out of 10 strains investigated, the lipase activity was signiﬁcantly
higher (p < 0.05) in bioﬁlms grown on artiﬁcial sebum pellets than
in planktonic cultures, while for 2 strains the lipase activity was
signiﬁcantly lower (p< 0.05). Only 2 strains had signiﬁcantly higher
(p < 0.05) standardized slopes when comparing lipase production
in bioﬁlm on the pellet vs. in a MTP.
P. acnes is one of the predominant bacterial species on the hu-
man skin, favors the lipid-rich regions of the skin, and colonizes the
pilosebaceous unit. It is therefore not surprising that the genome of
this bacterium encodes multiple putative lipases, including GehA
and GehB [13,17]. GehA is thought to be the enzyme responsible for
most of the degradation of the triglycerides found in nascent sebum
[44]. Lysis of these triglycerides releases free fatty acids which are
inﬂammatory, while GehA itself is also a strong chemotactic and
has pro-inﬂammatory activity [45]. In addition, free fatty acids
released fromnascent sebum cause ductal hypercorniﬁcation of the
pilosebaceous unit and cause keratinocytes to adhere to each other,
assisting in the formation of comedones. Additionally, these free
fatty acids also promote P. acnes cell-cell adhesion and adhesion to
the internal structures of the pilosebaceous unit, thus contributing
to colonization and bioﬁlm formation [8,17,45,46].
Protease production was assessed using the commercially
available EnzChek protease kit. Fluorescence could be observed in
all growth conditions, indicating the presence of protease (Fig. 4).
The production of protease was compared between the differentFig. 4. Fluorescence signals obtained with the Enzchek protease assay (normalized to 106 ce
n > 3). * Lower standardized signal in bioﬁlm grown on sebum pellet, compared to the sign
Wallis test.growth conditions and was either similar between groups or lower
in bioﬁlms produced on the pellet compared to in the bioﬁlm in a
MTP.
Protease production and excretion by P. acnes was already
described by Lee et al. [11] In the present study we demonstrated
the presence of protease in different growth conditions, including
in bioﬁlms formed on sebum pellets. In the pilosebaceous unit
protease can supply P. acnes with nutrients by breaking down host
tissue and it can activate the host immune response directly by
inducing an immune response from both keratinocytes and sebo-
cytes, the twomost important cells that make up the pilosebaceous
unit [11,12].
The production of CAMP factors, was determined using the
CAMP test. All tested P. acnes strains formed clear arrow heads on
5% sheep blood plates in the zones where S. aureus and P. acnes
converged, indicating the lysis of the sheep blood cells (Fig. 5a).
In the absence of S. aureus, isolated cells or supernatant from
planktonic or bioﬁlm cultures of P. acnes did not show hemolysis of
sheep blood, even in the presence of a suitable growth medium
(RCM) (data not shown). This lack of sheep blood hemolysis by
P. acnes alone is in accordance with the results of previously pub-
lished work [34] of our group, in which no hemolytic activity could
be found in P. acnes using horse blood. Next, the ability to co-
hemolyse sheep blood in combination with S. aureus supernatant
was determined. Overall, co-hemolysis occurred in all conditions
tested (Fig. 5b). For all strains tested, supernatant from planktonic
cultures and from bioﬁlm grown in MTP were able to co-hemolyse
sheep blood cells causing optical densities higher than the blank
(i.e. hemolysis by S. aureus alone). When bioﬁlms grown on the
artiﬁcial sebum pellets were tested, all but two strains, HL001PA1
and HL060PA1, were able to generate a positive co-hemolysis signal
as indicated in Fig. 5b. The results for these two strains are inlls). Bars represent averages and the error bars standard deviations (number of replicas
al generated in a bioﬁlm grown in a MTP (p < 0.05) as determined with the Kruskal-
Fig. 5. (a) Co-hemolysis of sheep blood by S. aureus and P. acnes. Clear arrow heads indicate complete lysis of the red blood cells where both the S. aureus produced toxin and the
P. acnes CAMP factors interact with the red blood cells. (b) Co-hemolysis by P. acnes in different growth conditions. * The signals that were not signiﬁcantly higher than blank signals
(i.e. hemolysis by S. aureus supernatant alone, p > 0.05), as determined with the t-test. Bars represent averages and the error bars standard deviations (number of replicas n > 3).
(For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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able to produce CAMP factors. These results are interesting as the
strains in question both belong to P. acnes type II, recently reclas-
siﬁed as P. acnes subsp. defendens, which is rarely associated with
acne. This outcome shows the importance of the microenviron-
ment on the production of certain virulence factors.
The genome of P. acnes contains ﬁve genes with sequence sim-
ilarity to the co-hemolytic CAMP factor produced by Streptococcus
agalactiae [13,16]. Co-hemolysis between CAMP factors and
S. aureus supernatant is caused by a synergistic effect of the CAMP
factors and an S. aureus toxin that acts as a sphingomyelinase. This
enzyme breaks down sphingomyelin, which is an integral part of
mammalian cell membranes, making them more vulnerable to the
membrane pore-forming CAMP factors [47].
In the present study, we conﬁrmed the ability of P. acnes to co-
hemolyse sheep blood in combination with supernatant of
S. aureus, irrespective of the mode of growth, in all but two strains.
The production of these CAMP factors could be an important
component in the etiology of acne. Studies have shown that these
factors are both secreted and cell-associated and belong to themost
abundantly secreted proteins in P. acnes [16,17,48]. CAMP factors
can activate the human immune system directly through binding
with TLR-2, or indirectly due to the combined effect with host
produced sphingomyelinase, which weakens cellular lining,
causing an invasion by P. acnes in the dermis as a result [15,49,50].4. Conclusion
We developed a new model, based on artiﬁcial sebum, to study
P. acnes bioﬁlms. The artiﬁcial sebum model sustains P. acnes
growth and bioﬁlm formationwhile mimicking some key aspects of
the pilosebaceous unit. We have also shown that the model can be
used in a wide range of experiments ranging from microscopy to
the detection of the production of certain virulence factors that
might be relevant in the pathogenesis of acne.Funding
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